Pharmadax Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 287.203 million compared to TWD 34.577 million a year ago. Operating loss was TWD 327.098 million compared to TWD 447.186 million a year ago. Net loss was TWD 314.927 million compared to TWD 470.423 million a year ago. Basic loss per share from continuing operations was TWD 5.02 compared to TWD 8 a year ago.